Claus L. Andersen

24.9k total citations · 2 hit papers
154 papers, 13.3k citations indexed

About

Claus L. Andersen is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Claus L. Andersen has authored 154 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Cancer Research, 68 papers in Molecular Biology and 58 papers in Pathology and Forensic Medicine. Recurrent topics in Claus L. Andersen's work include Cancer Genomics and Diagnostics (55 papers), Genetic factors in colorectal cancer (53 papers) and Colorectal Cancer Treatments and Studies (23 papers). Claus L. Andersen is often cited by papers focused on Cancer Genomics and Diagnostics (55 papers), Genetic factors in colorectal cancer (53 papers) and Colorectal Cancer Treatments and Studies (23 papers). Claus L. Andersen collaborates with scholars based in Denmark, United States and Finland. Claus L. Andersen's co-authors include Torben F. Ørntoft, Jens Ledet Jensen, Søren Laurberg, Lars Dyrskjøt, Kasper Thorsen, Troels Schepeler, Mogens Kruhøffer, Jesper B. Bramsen, Philippe Lamy and Thomas Reinert and has published in prestigious journals such as Nature, Nucleic Acids Research and Nature Communications.

In The Last Decade

Claus L. Andersen

150 papers receiving 13.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets

2004 5.9k citations Claus L. Andersen, Jens Ledet Jensen et al. Cancer Research profile →
An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes

2017 353 citations Dorte B. Bekker‐Jensen, Jesper B. Bramsen et al. profile →

Peers

Countries citing papers authored by Claus L. Andersen

Since Specialization

Citations

This map shows the geographic impact of Claus L. Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus L. Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus L. Andersen more than expected).

Fields of papers citing papers by Claus L. Andersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claus L. Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus L. Andersen. The network helps show where Claus L. Andersen may publish in the future.

Co-authorship network of co-authors of Claus L. Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Claus L. Andersen. A scholar is included among the top collaborators of Claus L. Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claus L. Andersen. Claus L. Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Whole‐genome sequencing of cell‐free DNA reveals DNA of tumor origin in plasma from patients with colorectal adenomas 2025 ·Molecular Oncology ·Amanda Frydendahl, Adam J. Widman, (unknown), (unknown), (unknown), Jesper Nors, Johanne Ahrenfeldt, Tenna Vesterman Henriksen, Christina Demuth, Line Raaby, Mads H. Rasmussen, Christina Therkildsen, Dan A. Landau, Claus L. Andersen	0
2	Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal Cancer 2025 ·Clinical Cancer Research ·Tenna Vesterman Henriksen, Christina Demuth, Amanda Frydendahl, Jesper Nors, (unknown), Mads H. Rasmussen, Ole H. Larsen, (unknown), (unknown), (unknown), (unknown), Ole Thorlacius‐Ussing, (unknown), (unknown), (unknown), Nis H. Schlesinger, Lene Hjerrild Iversen, Kåre Andersson Gotschalck, Claus L. Andersen	2
3	Proteomics of colorectal tumors identifies the role of CAVIN1 in tumor relapse 2025 ·Molecular Systems Biology ·Ana Martínez‐Val, (unknown), Dorte B. Bekker‐Jensen, Arne Lund Jørgensen, Jesper Nors, Giulia Franciosa, Claus L. Andersen, Jesper B. Bramsen, Jesper V. Olsen	1
4	Cell-free DNA approaches for cancer early detection and interception 2023 ·Journal for ImmunoTherapy of Cancer ·Jamie E. Medina, Nicholas C. Dracopoli, Peter B. Bach, (unknown), Robert B. Scharpf, Gerrit A. Meijer, Claus L. Andersen, Victor E. Velculescu	42
5	DREAMS: deep read-level error model for sequencing data applied to low-frequency variant calling and circulating tumor DNA detection 2023 ·Genome biology ·(unknown), (unknown), Mads H. Rasmussen, Amanda Frydendahl, Iben Lyskjær, Christina Demuth, Jesper Nors, Kåre Andersson Gotschalck, Lene Hjerrild Iversen, Claus L. Andersen, Jakob Skou Pedersen	5
6	ctDNA for Risk of Recurrence Assessment in Patients Treated with Neoadjuvant Treatment: A Systematic Review and Meta-analysis 2022 ·Annals of Surgical Oncology ·Mikail Gögenur, (unknown), Camilla Qvortrup, Claus L. Andersen, Ismail Gögenür	9
7	Transposon-activated POU5F1B promotes colorectal cancer growth and metastasis 2022 ·Nature Communications ·Laia Simó‐Riudalbas, Sandra Offner, Evarist Planet, Julien Duc, Laurence Abrami, (unknown), Alexandre Coudray, Mairene Coto‐Llerena, Caner Ercan, Salvatore Piscuoglio, Claus L. Andersen, Jesper B. Bramsen, Didier Trono	14
8	Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer 2017 ·Clinical Cancer Research ·Lone V. Schøler, Thomas Reinert, Mai‐Britt W. Ørntoft, (unknown), Sigrid S. Árnadóttir, Søren Vang, Iver Nordentoft, Michael Knudsen, Philippe Lamy, Ditte Andreasen, Frank Viborg Mortensen, Anders Riegels Knudsen, Katrine Stribolt, Kim Sivesgaard, Peter Mouritzen, Hans Jørgen Nielsen, Søren Laurberg, Torben F. Ørntoft, Claus L. Andersen	230
9	The non-coding variant rs1800734 enhances DCLK3 expression through long-range interaction and promotes colorectal cancer progression 2017 ·Nature Communications ·Ning Qing Liu, Menno ter Huurne, Luan N. Nguyen, Tianran Peng, Shuang-Yin Wang, James B. Studd, Onkar Joshi, Halit Ongen, Jesper B. Bramsen, Jian Yan, Claus L. Andersen, Jussi Taipale, Emmanouil T. Dermitzakis, Richard S. Houlston, Nina C. Hubner, Hendrik G. Stunnenberg	46
10	Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis 2011 ·BMC Genomics ·Kasper Thorsen, Troels Schepeler, Bodil Øster, Mads H. Rasmussen, Søren Vang, Kai Wang, (unknown), Philippe Lamy, Jakob Skou Pedersen, (unknown), Francisco Mansilla, Kirsti Laurila, Carsten Wiuf, Søren Laurberg, Lars Dyrskjøt, Torben F. Ørntoft, Claus L. Andersen	52
11	Blockage of Receptor for Advanced Glycation End Products Prevents Development of Cardiac Dysfunction in db/db Type 2 Diabetic Mice 2009 ·European Journal of Heart Failure ·Jan M. Nielsen, Steen Buus Kristiansen, Rikke Nørregaard, Claus L. Andersen, Larry Denner, Torsten Toftegaard Nielsen, Allan Flyvbjerg, Hans Erik Bøtker	54
12	Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro 2009 ·Cancer Research ·Lars Dyrskjøt, Marie S. Ostenfeld, Jesper B. Bramsen, Asli Silahtaroglu, Philippe Lamy, Ramshanker Ramanathan, Niels Fristrup, Jens Ledet Jensen, Claus L. Andersen, Karsten Zieger, Sakari Kauppinen, Benedicte Parm Ulhøi, Jørgen Kjems, Michael Borre, Torben F. Ørntoft	315
13	Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer 2009 ·Clinical Cancer Research ·Robert N. Jorissen, Peter Gibbs, Michael Christie, Saurabh Prakash, Lara Lipton, Jayesh Desai, Rachel Kerr, Lauri A. Aaltonen, Diego Arango, Mogens Kruhøffer, Torben F. Ørntoft, Claus L. Andersen, Mike Gruidl, Vidya Kamath, Steven A. Eschrich, Timothy J. Yeatman, Oliver M. Sieber	343
14	Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer 2008 ·Cancer Research ·Troels Schepeler, Thomas Reinert, Marie S. Ostenfeld, Lise L. Christensen, Asli Silahtaroglu, Lars Dyrskjøt, Carsten Wiuf, Frank J. Sørensen, Mogens Kruhøffer, Søren Laurberg, Sakari Kauppinen, Torben F. Ørntoft, Claus L. Andersen	419
15	DNA Copy-Number Alterations Underlie Gene Expression Differences between Microsatellite Stable and Unstable Colorectal Cancers 2008 ·Clinical Cancer Research ·Robert N. Jorissen, Lara Lipton, Peter Gibbs, Matthew Chapman, Jayesh Desai, Ian T. Jones, Timothy J. Yeatman, Philip East, Ian Tomlinson, Hein W. Verspaget, Lauri A. Aaltonen, Mogens Kruhøffer, Torben F. Ørntoft, Claus L. Andersen, Oliver M. Sieber	75
16	p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest 2008 ·Cancer Research ·Christian Braun, Xin Zhang, (unknown), Sonja Wolff, Ute M. Moll, Troels Schepeler, Torben F. Ørntoft, Claus L. Andersen, Matthias Dobbelstein	388
17	Role of Activating Fibroblast Growth Factor Receptor 3 Mutations in the Development of Bladder Tumors 2005 ·Clinical Cancer Research ·Karsten Zieger, Lars Dyrskjøt, Carsten Wiuf, Jens Ledet Jensen, Claus L. Andersen, Klaus Møller‐Ernst Jensen, Torben F. Ørntoft	76
18	Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization 2005 ·Cancer Genetics and Cytogenetics ·Claus L. Andersen, Alicja Gruszka, Shayne Atkinson, Estella Matutes, Daniel Catovsky, (unknown), Bjarne Bach Pedersen, (unknown), Peter Hokland, (unknown), Jørn Koch	16
19	Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets breakdown → 2004 ·Cancer Research ·Claus L. Andersen, Jens Ledet Jensen, Torben F. Ørntoft	5912
20	Improved procedure for fluorescence in situ hybridization on tissue microarrays 2001 ·Cytometry ·Claus L. Andersen, Galen Hostetter, Artyom M. Grigoryan, Guido Sauter, Anne Kallioniemi	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact